Biora Therapeutics to Present at H.C. Wainwright Conference
Biora Therapeutics, Inc. (Nasdaq: BIOR), an innovative biotech company focused on improving therapeutic delivery methods, has announced its participation in the H.C. Wainwright 26th Annual Global Investment Conference. This prestigious event will be held from September 9 to September 11, where Biora's leadership team will discuss their groundbreaking approaches.
Event Details
The H.C. Wainwright 26th Annual Global Investment Conference provides a valuable opportunity for Biora Therapeutics to connect with investors. The company will conduct a presentation and hold one-on-one meetings during the event.
Date and Time
Biora's presentation is set for Wednesday, September 11, 2024, starting at 2:00 PM Eastern time. This timing has been carefully chosen to maximize engagement with attendees and participants.
Webcast Information
Those interested will have the chance to access a live webcast of Biora Therapeutics’ presentation. Additionally, a replay of the event will be available, allowing those who cannot attend to benefit from the insights shared.
About Biora Therapeutics
Biora Therapeutics is dedicated to developing innovative therapeutics aimed at transforming patient care. The company focuses on two main platforms: the NaviCap™ platform and the BioJet™ platform. The NaviCap™ platform is specifically designed for colon-targeted treatment of inflammatory bowel disease (IBD), with the goal of improving patient outcomes by delivering treatment directly to the affected areas within the gastrointestinal tract.
Conversely, the BioJet™ platform enables the oral delivery of large molecules. This platform represents a significant leap forward by providing needle-free, oral delivery options, thereby improving the management of chronic diseases for patients who prefer non-invasive treatment methods.
Innovative Therapeutics and Future Potential
Biora Therapeutics is leading the way in biotech innovation, committed to enhancing the therapeutic experience in terms of both efficacy and patient comfort. The company’s platforms are tailored to address current medical challenges, including the increasing demand for non-invasive treatment options and the necessity for targeted therapies in chronic disease management.
Strategic Partnerships and Collaborations
To achieve its objectives, Biora Therapeutics actively pursues strategic partnerships that bolster its research capabilities and broaden its presence in the therapeutic market. Collaborating with healthcare professionals and other biotech companies is essential for advancing its treatment modalities.
Commitment to Regulatory Standards
For Biora Therapeutics, adherence to regulatory standards is crucial. The company is dedicated to maintaining transparency and fulfilling all necessary guidelines to ensure the safety and effectiveness of its products. This commitment fosters trust among patients, investors, and regulatory bodies.
Investor Relations and Contact Information
Biora Therapeutics values open communication with investors and interested parties. For more information about the company or its products, investors can contact Chuck Padala, Managing Director at LifeSci Advisors, at IR@bioratherapeutics.com or by phone at (646) 627-8390.
Media Inquiries
For media inquiries, Liz Robinson from CG Life is available at lrobinson@cglife.com. Biora Therapeutics recognizes the importance of media in sharing essential information about its innovations and initiatives.
Frequently Asked Questions
What is the H.C. Wainwright Conference?
The H.C. Wainwright Conference is an annual investment event that gathers leading companies from the biotech industry to showcase their developments to investors and stakeholders.
When will Biora Therapeutics present at the conference?
Biora Therapeutics is scheduled to present on Wednesday, September 11, 2024.
What are the NaviCap™ and BioJet™ platforms?
The NaviCap™ platform focuses on colon-targeted therapy for IBD, while the BioJet™ platform enables the oral delivery of large molecules, offering needle-free options for patients.
How can investors contact Biora Therapeutics?
Investors can reach out to Chuck Padala, Managing Director at LifeSci Advisors, by emailing IR@bioratherapeutics.com or calling (646) 627-8390.
Where can I find more information about Biora Therapeutics?
For more detailed information about Biora Therapeutics' offerings and innovations, you can visit their official website.
